Cell Biotech Co., Ltd. (KOSDAQ:049960)

Ligand Pharmaceuticals Revenue

Cell Biotech had revenue of 11.23B KRW in the quarter ending March 31, 2025, a decrease of -13.87%. This brings the company's revenue in the last twelve months to 48.10B, down -10.89% year-over-year. In the year 2024, Cell Biotech had annual revenue of 49.91B, down -7.20%.

• Revenue (ttm): 48.10B
• Revenue Growth: -10.89%
• P/S Ratio: 1.87
• Revenue / Employee: 453.81M
• Employees: 106
• Market Cap: 89.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	49.91B	-3.87B	-7.20%
Dec 31, 2023	53.79B	3.26B	6.46%
Dec 31, 2022	50.53B	3.65B	7.79%
Dec 31, 2021	46.87B	1.29B	2.83%
Dec 31, 2020	45.58B	-377.42M	-0.82%